Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. "The 3/1 Study".

@article{HamelDesnos2007ComparisonO1,
  title={Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. "The 3/1 Study".},
  author={Claudine Hamel-Desnos and Pierre Ouvry and Jean P Benigni and G Boitelle and Michel Schadeck and Philippe Desnos and F. A. Allaert},
  journal={European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery},
  year={2007},
  volume={34 6},
  pages={723-9; discussion 730}
}
OBJECTIVES To compare 1% and 3% POL foam in treating the great saphenous vein (GSV) by ultrasound guided sclerotherapy. DESIGN Multicentre, prospective, randomised, double-blind trial with 2 year-follow-up. PATIENTS AND METHODS 148 patients with GSV reflux (saphenous trunk diameter 4-8 mm) were randomised to undergo ultrasound guided foam sclerotherapy using either 1% or 3% POL foam in a single session. Foam production was standardised using a sterile disposable syringe kit including… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 43 extracted citations

Properties of polidocanol foam in view of its use in sclerotherapy.

International journal of pharmaceutics • 2015
View 3 Excerpts
Highly Influenced

Treatment of 63 Subjects With Digital Mucous Cysts With Percutaneous Sclerotherapy Using Polidocanol.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] • 2016
View 1 Excerpt

Ultrasound-guided foam sclerotherapy of great saphenous vein with 2% polidocanol – one-year follow-up results

Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques • 2016
View 2 Excerpts

Similar Papers

Loading similar papers…